Literature DB >> 890666

A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

J L Binet, M Leporrier, G Dighiero, D Charron, P D'Athis, G Vaugier, H M Beral, J C Natali, M Raphael, B Nizet, J Y Follezou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 890666     DOI： 10.1002/1097-0142(197708)40:2<855::aid-cncr2820400239>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  64 in total

Review 1.  Eradication of minimal residual disease in chronic lymphocytic leukemia.

Authors:  Carmen Diana Schweighofer; Michael Hallek; Clemens-Martin Wendtner
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

2.  Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).

Authors:  M Freund; S Wunsch-Zeddies; M Schäfers; J Wysk; I Seidel; W Hiddemann; A R Hanauske; H Link; H J Schmoll; H Poliwoda
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

3.  Prognostic significance of the heterogenous expression of IgG Fc receptors in B-cell chronic lymphocytic leukemia.

Authors:  V Schranz; F Gráf
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

Review 4.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

5.  CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.

Authors:  David Gonzalez; Monica Else; Dorte Wren; Monica Usai; Anne Mette Buhl; Anton Parker; David Oscier; Gareth Morgan; Daniel Catovsky
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

6.  TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner.

Authors:  Inbal Binsky; Frida Lantner; Valentin Grabovsky; Nurit Harpaz; Lev Shvidel; Alain Berrebi; David M Goldenberg; Lin Leng; Richard Bucala; Ronen Alon; Michal Haran; Idit Shachar
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

7.  Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.

Authors:  Patricia Dos Santos; Julieta Panero; Virginia Palau Nagore; Carmen Stanganelli; Raimundo F Bezares; Irma Slavutsky
Journal:  Tumour Biol       Date:  2015-05-26

Review 8.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

9.  CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.

Authors:  Hadas Lewinsky; Avital F Barak; Victoria Huber; Matthias P Kramer; Lihi Radomir; Lital Sever; Irit Orr; Vita Mirkin; Nili Dezorella; Mika Shapiro; Yosef Cohen; Lev Shvidel; Martina Seiffert; Yair Herishanu; Shirly Becker-Herman; Idit Shachar
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

10.  Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia.

Authors:  Eloisa Jantus Lewintre; Cristina Reinoso Martín; Carlos García Ballesteros; David Montaner; Rosa Farrás Rivera; José Ramón Mayans; Javier García-Conde
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.